Objective: To identify additional loci associated with depression and the hippocampus (HIP) through genome-wide association study.

Methods: The depression-related genome-wide association study (GWAS) meta summary data was downloaded from the official website of the Psychiatric Genomics Consortium, which had involved 170 756 cases and 329 443 controls. The left and right hippocampal volume GWAS data sets were downloaded from the UK Biobank, which involved 33 224 participants. The conditional false discovery rate (condFDR) was used to identify novel genetic loci for depression and left and right hippocampal volumes, and a conjunctional false discovery rate (conjFDR) was used to evaluate the enrichment of pleiotropic loci between depression and left and right hippocampal volumes.

Results: Respectively, 7, 13, and 12 new loci have been associated with depression, left hippocampal volume and right hippocampal volume, with a significant threshold of condFDR < 0.01. A site of rs1267073 locus was found to be shared by the depression and right hippocampal volume with a threshold of conjFDR < 0.01.

Conclusion: Above findings have provided more insights into the genetic mechanisms underlying the volume of hippocampus and the risk for depression. The results may also provide evidence for future clinical trials for treating depression.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn511374-20230515-00285DOI Listing

Publication Analysis

Top Keywords

left hippocampal
16
hippocampal volume
16
loci associated
12
depression left
12
novel genetic
8
genetic loci
8
associated depression
8
genome-wide association
8
false discovery
8
discovery rate
8

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South).

Background: Normative percentile (NP) quantifies brain atrophy by comparing regional brain volumes of a subject against age and sex-matched cognitively normal populations. Accurate intracranial volume (ICV) adjustment is vital in NP quantification to minimize the effect of an individual's head size. However, which intracranial volume adjustment method yields reliable normative percentiles remains unclear.

View Article and Find Full Text PDF

Background: Women with suspected coronary microvascular dysfunction (CMD) may be at higher risk of experiencing cognitive decline due to cerebral small vessel disease, a known contributor to Alzheimer's disease and related dementias (ADRD). A potential underlying mechanism that could accelerate this cognitive decline is the accumulation of brain tissue iron, which has been previously linked to changes in brain function potentially caused by oxidative stress and cell death. Therefore, we aim to elucidate whether a similar mechanism could affect women with suspected CMD by investigating the potential role of iron deposition on the brain's functional organization and its effect on cognition using advanced magnetic resonance imaging (MRI).

View Article and Find Full Text PDF

Background: About 20-30% of clinically diagnosed AD dementia patients do not meet pathologic criteria for AD and this proportion is even higher in amnestic MCI. Among tau-negative amnestic patients, limbic-predominant age-related TDP-43 encephalopathy (LATE) has been described as a principal diagnostic alternative, especially at advanced age. LATE is characterized by a specific temporo-limbic hypometabolic signature on FDG-PET that may aid in differential diagnosis.

View Article and Find Full Text PDF

Background: The APOE4 genotype appears to confer differential risk of Alzheimer's disease for women compared to men. As APOE4 effects in midlife women can be subtle (e.g.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Eisai Inc., Nutley, NJ, USA.

Background: Reductions in medial temporal lobe (MTL) volume, particularly in the amygdala and hippocampus, are present in early Alzheimer's disease (AD). We explore the correlations between hippocampal and amygdalar subfield volumes and brain amyloid-β (Aβ) accumulation using T1-weighted structural MRI and amyloid PET data from ADNI and Eisai clinical trials.

Method: We used FreeSurfer (v7.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!